Evidence map›Paper›PMID 28332888›Full record

Trial reportJournal of women's health (2002)2017

Clinician and Patient Acceptability of Self-Collected Human Papillomavirus Testing for Cervical Cancer Screening.

Constance Mao, Shalini L Kulasingam, Hilary K Whitham, Stephen E Hawes, John Lin, Nancy B Kiviat

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of women's health (2002), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 2 syntheses or guidelines pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Constance Mao1 Department of Obstetrics and Gynecology, University of Washington School of Medicine , Seattle, Washington.
Shalini L Kulasingam2 Division of Epidemiology and Community Health, University of Minnesota School of Public Health , Minneapolis, Minnesota.
Hilary K Whitham2 Division of Epidemiology and Community Health, University of Minnesota School of Public Health , Minneapolis, Minnesota.
Stephen E Hawes3 Department of Epidemiology, University of Washington School of Medicine , Seattle, Washington.
John Lin4 Department of Pathology, University of Washington School of Medicine , Seattle, Washington.
Nancy B Kiviat4 Department of Pathology, University of Washington School of Medicine , Seattle, Washington.
University of Washington · USUniversity of Minnesota · US

Funding

Cytology vs at home HPV screening for detection of CIN 2,3,CISR01CA157469 · NCI · UNIVERSITY OF WASHINGTON · PI KIVIAT, NANCY B., KULASINGAM, SHALINI L. · 2011 to 2015
$3.0M
NCI NIH HHS R01 CA157469
6 · The paper itself

Abstract

backgroundTo evaluate clinician and patient attitudes toward home self-collected human papillomavirus (HPV) testing for cervical cancer screening.

methodsWomen aged 21-65 years were recruited for a randomized trial comparing home self-collected HPV testing to standard clinician-collected Pap screening. Participants were surveyed about their attitudes toward self-collected HPV testing. Clinicians performing cervical cancer screening in University of Washington medical clinics were also surveyed to determine their acceptability of self-collected HPV testing.

resultsOver half (59.1%) of the 1,769 women surveyed preferred self-collected HPV testing to clinician-collected tests. Reasons most often cited were convenience or time saving (82.7%), and avoiding embarrassment or discomfort associated with pelvic exam (38.1%). Women who did not prefer self-collected HPV testing reported greater faith in clinician-collected samples (56.7%) or a desire for a clinic visit to address other issues (42.4%). One hundred eighteen (49.6%) of 238 physicians and midlevel providers surveyed completed the survey. The majority (78.0%) reported that they would recommend a self-collected HPV test if the test had qualities such as high sensitivity and cost effectiveness. Provider concerns mirrored those of patients, namely ensuring adequate sample collection and the opportunity to address other health concerns.

conclusionPatients and clinicians are supportive of self-collected HPV testing. However, concerns regarding adequacy of samples that are self collected and the desire to see a provider in a clinic setting for other health needs highlight areas that need to be addressed if self collection proves to be a viable option for cervical cancer screening.

Indexed as

Attitude of Health PersonnelPatient Acceptance of Health CareSelf CareUterine Cervical DysplasiaUterine Cervical NeoplasmsAdultAgedFemaleHumansMiddle AgedPapanicolaou TestPapillomaviridaePapillomavirus InfectionsProcess Assessment, Health CareVaginal SmearsYoung Adultcervical cancerHPVPapscreeningself-collected

Identifiers

PMID28332888
PMCPMC5512311
OpenAlexW2602269575

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.